Product
RNA Transcription Modulator AU-409
1 clinical trial
6 indications
Indication
CholangiocarcinomaIndication
Hepatocellular CarcinomaIndication
Malignant NeoplasmIndication
Liver MetastasisIndication
Malignant Solid NeoplasmClinical trial
First in Human Dose Escalation Study of AU409 in Patients With Advanced Primary Liver Cancers or Advanced Solid Tumor With Liver Predominant Metastatic DiseaseStatus: Recruiting, Estimated PCD: 2026-03-29